As shown in the endometrial cancer pathway (hsa05213), both BAX and BIRC5 are Astragalus membranaceus targets that can inhibit tumour proliferation (Huo et al., 2019; Sakuragi et al., 2002). Here, BAX is linked to neoplasm.